Simultaneous Population-Based Testing

Simultaneous Population-Based Testing

ASGE Journal Scan | Kolon

Simultaneous Population-Based Testing for Specific Cancer Genes, Including Lynch Syndrome, Found Conditionally Cost-Effective

According to data, 1.5% of the U.S. population has hereditary breast and ovarian cancer syndrome (0.72%), Lynch syndrome (0.35%), or familial hypercholesterolemia (FH; 0.43%). This

JETZT ANSEHEN

Nach oben scrollen